Literature DB >> 7792786

Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.

H Makino1, S Sato, A Yajima, S Komatsu, A Fukao.   

Abstract

To estimate the effectiveness of screening for invasive cervical cancer, a case-control study was performed in Miyagi, Japan. A total of 198 cases (129 mass screen-detected and 69 outpatient-detected) of invasive cervical cancer were identified between 1984 and 1990. The results of the Papanicolaou smear of these cases were compared to those of 396 age- (+/- 5 years) and area-matched controls. Compared with women who had no prior screening (cases 51.6%, controls 16.2%), women who were screened had an odds ratio (OR) for invasive cervical cancer of 0.14 (95% confidence interval [CI] 0.088-0.230). The OR for the 175 cases of squamous cell carcinoma was 0.13 (95% CI 0.077-0.215), while the OR for the 23 cases of screened women with adenocarcinoma was 0.40 (95% CI 0.091-1.753). The time intervals following the last negative smear were assessed and we found an OR for a one-year interval and a two-year interval of 0.09 (95% CI 0.055-0.163) and 0.17 (95% CI 0.083-0.335), respectively. In conclusion, screening for invasive cervical cancer is not only effective but also the degree of protection is high for one to two years.

Entities:  

Mesh:

Year:  1995        PMID: 7792786     DOI: 10.1620/tjem.175.171

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  6 in total

1.  Recommendations on screening for cervical cancer.

Authors:  James Dickinson; Eva Tsakonas; Sarah Conner Gorber; Gabriela Lewin; Elizabeth Shaw; Harminder Singh; Michel Joffres; Richard Birtwhistle; Marcello Tonelli; Verna Mai; Meg McLachlin
Journal:  CMAJ       Date:  2013-01-07       Impact factor: 8.262

2.  Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study.

Authors:  S Y Liao; W H Rodgers; J Kauderer; K M Darcy; R Carter; N Susumu; S Nagao; J L Walker; M Hatae; E J Stanbridge
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

3.  Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study.

Authors:  S-Y Liao; W H Rodgers; J Kauderer; T A Bonfiglio; K M Darcy; R Carter; L Levine; N M Spirtos; N Susumu; K Fujiwara; J L Walker; M Hatae; E J Stanbridge
Journal:  Br J Cancer       Date:  2010-12-14       Impact factor: 7.640

4.  Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.

Authors:  Alejandra Castanon; Aruna Kamineni; K Miriam Elfström; Anita W W Lim; Peter Sasieni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-14       Impact factor: 4.254

5.  The Korean guideline for cervical cancer screening.

Authors:  Kyung Jin Min; Yoon Jae Lee; Mina Suh; Chong Woo Yoo; Myong Cheol Lim; Jaekyung Choi; Moran Ki; Yong Man Kim; Jae Weon Kim; Jea Hoon Kim; Eal Whan Park; Hoo Yeon Lee; Sung Chul Lim; Chi Heum Cho; Sung Ran Hong; Ji Yeon Dang; Soo Young Kim; Yeol Kim; Won Chul Lee; Jae Kwan Lee
Journal:  J Gynecol Oncol       Date:  2015-07       Impact factor: 4.401

Review 6.  Screening for cervical cancer: a systematic review and meta-analysis.

Authors:  Leslea Peirson; Donna Fitzpatrick-Lewis; Donna Ciliska; Rachel Warren
Journal:  Syst Rev       Date:  2013-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.